| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0000200 | Intergenic-Exon | chr6:146121313-146216113 | chr6:145800177-145894977 | 250 nt | 0.3640 |
| hsa_SHPRH_0000500 | Intergenic-Exon | chr6:146142754-146216113 | chr6:145821618-145894977 | 93 nt | 0.4731 |
| hsa_SHPRH_0000600 | Intergenic-Exon | chr6:146179321-146216113 | chr6:145858185-145894977 | 250 nt | 0.3240 |
| hsa_SHPRH_0000700 | Intergenic-Exon | chr6:146179578-146216113 | chr6:145858442-145894977 | 186 nt | 0.3978 |
| hsa_SHPRH_0000800 | Intergenic-Exon | chr6:146179593-146216113 | chr6:145858457-145894977 | 93 nt | 0.4731 |
| hsa_SHPRH_0001300 | Exon-Exon | chr6:146185524-146209236 | chr6:145864388-145888100 | 185 nt | 0.4054 |
| hsa_SHPRH_0001400 | Exon-Intergenic | chr6:146185524-146214529 | chr6:145864388-145893393 | 185 nt | 0.4054 |
| hsa_SHPRH_0001500 | Exon-Intergenic | chr6:146185524-146215372 | chr6:145864388-145894236 | 185 nt | 0.4054 |
| hsa_SHPRH_0001800 | Exon-Intergenic | chr6:146185524-146216142 | chr6:145864388-145895006 | 128 nt | 0.4219 |
| hsa_SHPRH_0001000 | Intergenic-Exon | chr6:146185524-146239368 | chr6:145864388-145918232 | 250 nt | 0.3200 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].